Infection, inflammation and colon carcinogenesis
Name
Dedon_Infection Inflammation.pdf
Size
423.28 KB
Format
Adobe PDF
Checksum (MD5)
b8f600956cc3a4ab25782ec02b56ed40
Author(s)
Wogan, Gerald N.
Dedon, Peter C.
Tannenbaum, Steven Robert
Fox, James G.
Date Issued
August 2012
Journal
Oncotarget
Publisher
Impact Journals
Citation
Wogan, G.N. et al. "Infection, inflammation and colon carcinogenesis." Oncotarget 3.8 (2012): 737–738. Web.
Version
Final published version
Abstract
The importance of chronic inflammation as a risk factor for major cancers is well documented [1], and the inflammatory state is known to involve contributions of both adaptive and innate immune components. In a recent publication [2] we describe an experimental animal model in which infection, inflammation and cancer are mechanistically linked, and provide evidence that chemical mediators of the innate immune system and bacterial toxins both play key roles in driving colon carcinogenesis. In this model, epithelial injury caused by Helicobacter hepaticus infection enhances access of bacterially-associated products to pattern-recognition receptors located on surfaces of macrophages and dendritic cells. Receptor ligation leads to activation of transcription factors, including NF-kappa B, that regulate production of chemo-attractants for macrophages and neutrophils, recruitment of which is a hallmark of inflammation. These acute inflammatory events are re-enforced by expression of powerful inflammatory mediators such as TNF-α and IL-2, which amplify acute inflammatory gene expression and enhance cell survival. If not properly extinguished, the innate inflammatory response is maintained and further amplified by activation of cell-mediated adaptive immunity.
MIT Department
Massachusetts Institute of Technology. Department of Biological Engineering
Massachusetts Institute of Technology. Department of Chemistry
Massachusetts Institute of Technology. Division of Comparative Medicine
Terms of Use
Creative Commons Attribution
Persistent DSpace Link
DOI of Published Version
http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=624&path%5B%5D=934
